Advertisement

EDITORIAL COMMENT

(re: Minimally Invasive Management of Rectourethral Fistulae)
      Although rare, rectourethral fistula (RUF) is a morbid pathology most commonly presenting as an iatrogenic defect in patients treated for prostate or rectal cancer. Increasing rates of prostate cancer detection and concurrent use of energy therapies for pelvic malignancies have led to an increased incidence of RUF. An estimated 0.1%-3% of patients undergoing external beam radiation therapy, brachytherapy, and/or cryotherapy for prostate or rectal cancer present with RUF.
      • Hechenbleikner E.M.
      • Buckley J.C.
      • Wick E.C.
      Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes.
      Decreasing repair failures and complications of intervention are important when considering treatment approaches.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hechenbleikner E.M.
        • Buckley J.C.
        • Wick E.C.
        Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes.
        Dis Colon Rectum. 2013; 56: 374-383https://doi.org/10.1097/DCR.0b013e318274dc87
        • Medina L.G.
        • et al.
        Rectourethral fistula: operative technique and outcomes.
        Curr Bladder Dysfunction Rep. 2019; 14: 151-156https://doi.org/10.1007/s11884-019-00529-4